ClearPoint Neuro WKN: A2PZ3E ISIN: US18507C1036 Kürzel: CLPT Forum: Aktien Thema: Hauptdiskussion

12,10 USD
+4,13 %+0,48
9. Oct, 19:11:37 Uhr, Nasdaq
Kommentare 103
Vancouver
Vancouver, 11.01.2023 6:46 Uhr
0
=00=
Summer.76
Summer.76, 12.12.2022 17:20 Uhr
0
https://www.globenewswire.com/news-release/2022/12/12/2571981/0/en/ClearPoint-Neuro-Announces-First-Patient-Enrolled-in-Glioblastoma-Trial-Using-ClearPoint-Prism-Neuro-Laser-Therapy-System-at-Sk%C3%A5ne-University-Hospital-in-Sweden.html
Summer.76
Summer.76, 09.11.2022 5:40 Uhr
1
ClearPoint Neuro GAAP EPS of -$0.15, revenue of $5.1M https://seekingalpha.com/news/3904123-clearpoint-neuro-gaap-eps-of-0_15-revenue-of-5_1m • ClearPoint Neuro press release (NASDAQ:CLPT): Q3 GAAP EPS of -$0.15. Revenue of $5.1M vs $4.6M. • CLPT reaffirmed full year 2022 revenue outlook of between $21.0 and $22.0M. • Cash and short-term investments totaled $40.5M as of Sept 30, 2022. • CLPT said three new products were cleared by FDA in the quarter and are in the process of being deployed in limited market releases before the end of the year. • "We achieved another strong quarter for revenue despite a historically high case cancellation rate and hospital supply chain disruptions." - President and CEO Joe Burnett
Summer.76
Summer.76, 09.11.2022 5:40 Uhr
0
ClearPoint Neuro Reports Third Quarter 2022 Results https://www.globenewswire.com/news-release/2022/11/08/2551424/25687/en/ClearPoint-Neuro-Reports-Third-Quarter-2022-Results.html Company Reaffirms 2022 Revenue Forecast
Summer.76
Summer.76, 23.09.2022 12:13 Uhr
0
https://www.globenewswire.com/news-release/2022/09/23/2521573/0/en/ClearPoint-Neuro-Announces-FDA-Clearance-for-ClearPoint-Prism-Neuro-Laser-Therapy-System.html
Summer.76
Summer.76, 20.09.2022 6:27 Uhr
0
https://www.globenewswire.com/news-release/2022/09/19/2518720/0/en/ClearPoint-Neuro-Announces-FDA-Clearance-for-Software-Version-2-1.html
Summer.76
Summer.76, 10.08.2022 5:52 Uhr
0
ClearPoint Neuro Announces FDA Clearance for ClearPoint Maestro™ Brain Model https://www.globenewswire.com/news-release/2022/08/09/2495317/25687/en/ClearPoint-Neuro-Announces-FDA-Clearance-for-ClearPoint-Maestro-Brain-Model.html
Summer.76
Summer.76, 10.08.2022 5:52 Uhr
0
ClearPoint Neuro, Inc. Misses Q2 EPS by 16c https://m.investing.com/news/clearpoint-neuro-inc-misses-q2-eps-by-16c-432SI-2868428?ampMode=1
Summer.76
Summer.76, 03.06.2022 5:49 Uhr
0
https://www.globenewswire.com/news-release/2022/06/02/2455609/25687/en/ClearPoint-Neuro-Announces-Receipt-of-MDSAP-Certification.html
Summer.76
Summer.76, 20.05.2022 15:48 Uhr
0
ClearPoint Neuro Congratulates Partner PTC Therapeutics on Receiving Positive CHMP Opinion for Gene Therapy to Treat AADC Deficiency https://www.globenewswire.com/news-release/2022/05/20/2447753/0/en/ClearPoint-Neuro-Congratulates-Partner-PTC-Therapeutics-on-Receiving-Positive-CHMP-Opinion-for-Gene-Therapy-to-Treat-AADC-Deficiency.html First Gene Therapy Directly Infused into the Brain to be Administered with ClearPoint’s SmartFlow® Cannula
Summer.76
Summer.76, 12.05.2022 16:54 Uhr
0
https://www.fool.com/earnings/call-transcripts/2022/05/11/clearpoint-neuro-inc-clpt-q1-2022-earnings-call-tr/
Summer.76
Summer.76, 12.05.2022 5:27 Uhr
0
ClearPoint Neuro Reports First Quarter 2022 Results https://www.globenewswire.com/news-release/2022/05/11/2441245/25687/en/ClearPoint-Neuro-Reports-First-Quarter-2022-Results.html
Summer.76
Summer.76, 04.05.2022 17:30 Uhr
0
https://www.globenewswire.com/news-release/2022/05/03/2435061/25687/en/ClearPoint-Neuro-and-Higgs-Boson-Health-Announce-Collaboration.html
Summer.76
Summer.76, 29.04.2022 5:46 Uhr
0
ClearPoint Neuro Announces FDA Clearance of the SmartFrame Array™ Version 1.1 https://www.globenewswire.com/news-release/2022/04/28/2431949/0/en/ClearPoint-Neuro-Announces-FDA-Clearance-of-the-SmartFrame-Array-Version-1-1.html Next Generation Neuro Navigation System Designed for Use in Both the MRI Suite and Operating Room
Summer.76
Summer.76, 28.04.2022 6:37 Uhr
0
ClearPoint Neuro Expands Software License and Research Agreement with Philips to Power Expansion of the ClearPoint Platform into the Operating Room https://www.globenewswire.com/news-release/2022/04/27/2430700/25687/en/ClearPoint-Neuro-Expands-Software-License-and-Research-Agreement-with-Philips-to-Power-Expansion-of-the-ClearPoint-Platform-into-the-Operating-Room.html
Meistdiskutiert
Thema
1 Renk Group -2,32 %
2 VARTA Hauptdiskussion +85,71 %
3 BAYER Hauptdiskussion -6,60 %
4 Das neue Dax Prognose Forum +0,85 %
5 Trading- und Aktien-Chat
6 NVIDIA Hauptdiskussion -0,11 %
7 Palantir +4,28 %
8 Lilium Aktie +0,85 %
9 MicroStrategy +1,14 %
10 Nio für normale Kommunikation +0,52 %
Alle Diskussionen
Aktien
Thema
1 Renk Group -2,32 %
2 VARTA Hauptdiskussion +85,71 %
3 BAYER Hauptdiskussion -6,60 %
4 Palantir +4,28 %
5 NVIDIA Hauptdiskussion -0,11 %
6 Lilium Aktie +0,85 %
7 MicroStrategy +1,14 %
8 Nio für normale Kommunikation +0,52 %
9 Canopy Hauptforum -1,34 %
10 AIXTRON Hauptdiskussion -3,32 %
Alle Diskussionen